Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

646
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
646

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety, Immunogenicity, and Vaccine Compatibility of a Trivalent Inactivated In Ovo Nanovaccine Against Avian Colibacillosis in Broilers Under Commercial Hatchery Conditions.

Animals : an open access journal from MDPI·2026
Same author

Retrospective Analysis of the Impact of Vaccination with an Inactivated Vaccine on Toxoplasmosis-Associated Mortality in Captive Wildlife.

Vaccines·2025
Same author

T-cell activation of Toxoplasma gondii positive donors by maltodextrin nanoparticles formulated with killed Toxoplasma gondii.

BMC infectious diseases·2025
Same author

Tristetraprolin Family Members and Processing Bodies: A Complex Regulatory Network Involved in Fatty Liver Disease, Viral Hepatitis and Hepatocellular Carcinoma.

Cancers·2025
Same author

An untargeted metabolomic study using MALDI-mass spectrometry imaging reveals region-specific biomarkers associated with bowel inflammation.

Metabolomics : Official journal of the Metabolomic Society·2024
Same author

Inactivated <i>Toxoplasma gondii</i> nanovaccine boosts T-cell memory response in a seropositive yellow-footed rock wallaby (<i>Petrogale xanthopus</i>) - A case report from Copenhagen Zoo.

International journal for parasitology. Parasites and wildlife·2024

Related Experiment Video

Updated: Sep 3, 2025

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
07:32

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection

Published on: September 1, 2023

2.0K

Starch-based NP act as antigen delivery systems without immunomodulating effect.

François Fasquelle1, Laurent Dubuquoy2, Didier Betbeder1

  • 1Vaxinano, Loos, France.

Plos One
|July 29, 2022
PubMed
Summary
This summary is machine-generated.

Nasal immunization with starch nanoparticles (NPL) enhances antigen delivery without causing inflammation. This efficient delivery system alone is sufficient for inducing mucosal immunity, negating the need for immunomodulators.

More Related Videos

Cellular Affinity of Particle-Stabilized Emulsion to Boost Antigen Internalization
10:06

Cellular Affinity of Particle-Stabilized Emulsion to Boost Antigen Internalization

Published on: September 2, 2022

1.9K
Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion&#45;Encapsulated Retinoic Acid System for Mucosal Vaccination
06:02

Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination

Published on: February 23, 2024

770

Related Experiment Videos

Last Updated: Sep 3, 2025

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
07:32

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection

Published on: September 1, 2023

2.0K
Cellular Affinity of Particle-Stabilized Emulsion to Boost Antigen Internalization
10:06

Cellular Affinity of Particle-Stabilized Emulsion to Boost Antigen Internalization

Published on: September 2, 2022

1.9K
Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion&#45;Encapsulated Retinoic Acid System for Mucosal Vaccination
06:02

Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination

Published on: February 23, 2024

770

Area of Science:

  • Immunology
  • Nanotechnology
  • Cell Biology

Background:

  • Nasal immunization offers an alternative to injections, inducing both mucosal and systemic immunity.
  • Immunomodulators can enhance immune responses but may cause inflammation, limiting their use.
  • Starch nanoparticles (NPL) are investigated as delivery systems for nasal vaccines.

Purpose of the Study:

  • To investigate the mechanisms by which starch nanoparticles (NPL) enhance antigen immunogenicity in H292 epithelial cells.
  • To assess the immunomodulatory effects of NPL.
  • To determine if NPL can induce mucosal immunity without additional immunomodulators.

Main Methods:

  • In vitro study using H292 epithelial cells.
  • Evaluation of antigen (E. coli lysate) delivery and immunogenicity enhancement by NPL.
  • Comparison of reticulated (NPL) and non-reticulated (NPL·NR) starch nanoparticles.
  • Assessment of NPL's intrinsic immunomodulatory effects.

Main Results:

  • NPL enhanced antigen immunogenicity by increasing intracellular delivery, not through intrinsic immunomodulatory effects.
  • Particle density significantly influenced NPL efficiency, with reticulated particles showing different efficacy.
  • NPL demonstrated no inherent immunomodulatory effect on H292 cells.

Conclusions:

  • Efficient antigen delivery systems, like NPL, can enhance immunogenicity without requiring immunomodulators.
  • Starch nanoparticles are a promising platform for nasal vaccine development, capable of inducing mucosal immune responses.
  • The physical properties of nanoparticles, such as density, are critical for optimizing vaccine delivery efficacy.